MetaCap

Bio-Rad Laboratories (BIO) vs Mettler-Toledo International (MTD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

Bio-Rad Laboratories (BIO) has outperformed Mettler-Toledo International (MTD) over the past year, gaining 24.1% versus a gain of 17.1%. Over five years, MTD leads with a +8.2% price change compared with -49.0% for BIO. Mettler-Toledo International is the larger company by market cap ($30.73 billion vs $9.84 billion), about 3.1 times the size.

On valuation, Mettler-Toledo International trades at a lower forward P/E (29.6x vs 37.1x for Bio-Rad Laboratories). Bio-Rad Laboratories converts more of its revenue into profit, with a net margin of 29.4% versus 21.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BIO+24.08%MTD+17.14%
+34%+5%-24%
Oct 7, 20251 yearOct 7, 2026
BIO-49.07%MTD+10.70%
+27%-24%-74%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BIO versus MTD key metrics
MetricBIOMTD
Share price$367.92$1,533.48
Market cap$9.84B$30.73B
1-day change-0.25%+0.03%
YTD return+21.43%+9.99%
1-year return+24.08%+17.14%
5-year return-49.00%+8.16%
P/E ratio (TTM)46.6334.56
Forward P/E37.1029.62
EPS (TTM)$7.89$44.37
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.58B$4.03B
Revenue growth (YoY)+0.65%+3.98%
Net income (latest FY)$759.90M$869.19M
Gross margin51.87%59.37%
Operating margin1.83%—
Net margin29.42%21.59%
52-week high$396.23$1,585.72
52-week low$236.73$1,023.05
Distance from 52-week high-7.14%-3.29%
Analyst consensusholdhold
Avg. price target upside-10.76%-4.04%
Average volume277.32K183.40K
Shares outstanding21.68M20.04M
Employees7,45016,600
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Mettler-Toledo International is about 3.1 times larger than Bio-Rad Laboratories by market value ($30.73B vs $9.84B).
  • Bio-Rad Laboratories trades at a higher earnings multiple (46.6x vs 34.6x trailing P/E).
  • Bio-Rad Laboratories is more profitable, keeping 29.4 cents of every revenue dollar as net income versus 21.6 cents for Mettler-Toledo International.

About Bio-Rad Laboratories

BIO stock →

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.

Industrials · Biotechnology: Laboratory Analytical Instruments · 7,450 employees

About Mettler-Toledo International

MTD stock →

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

Industrials · Biotechnology: Laboratory Analytical Instruments · 16,600 employees

BIO vs MTD FAQ

Which is bigger, Bio-Rad Laboratories or Mettler-Toledo International?

Mettler-Toledo International (MTD) is larger, with a market capitalization of $30.73B compared with $9.84B for Bio-Rad Laboratories (BIO).

Which stock has performed better over the past year, BIO or MTD?

BIO returned +24.08% over the past 12 months, compared with +17.14% for MTD (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, BIO or MTD?

MTD has the lower trailing P/E at 34.6, versus 46.6 for BIO. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Bio-Rad Laboratories and Mettler-Toledo International in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons